Patients with ACVR1R206H mutations have an increased prevalence of cardiac conduction abnormalities on electrocardiogram in a natural history study of Fibrodysplasia Ossificans Progressiva.

ABSTRACT: BACKGROUND:Genetic contributors to cardiac arrhythmias are often found in cardiovascular conduction pathways and ion channel proteins. Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare disease of massive heterotopic ossification caused by a highly recurrent R206H mutation in ACVR1/ALK2. This mutation causes abnormal activation of the bone morphogenetic protein (BMP) pathway in response to Activin A. Prior studies suggested increased risks of cardiopulmonary complications in FOP. We examined participants in a Natural History Study (NHS) of FOP (ClinicalTrials.gov #NCT02322255) to better understand their cardiovascular status. METHODS:The NHS is an ongoing 3 year international multi-center longitudinal study of 114 patients (ages 4-56?years) with genetically confirmed ACVR1/ALK2R206H FOP. Patients were clinically assessed at baseline and 12?months. Electrocardiograms (ECGs) were reviewed in a central ECG laboratory. Conduction abnormalities were compared against clinical data collected in the NHS, and echocardiograms collected from NHS and non-NHS patients. RESULTS:Conduction abnormalities were present in 45.3% of baseline ECGs, with the majority of abnormalities classified as nonspecific intraventricular conduction delay (37.7%). More specifically, 22.2% of patients >?18?years old had conduction abnormalities, which was significantly higher than a prior published study of a healthy population (5.9%; n =?3978) (p 

SUBMITTER: Kou S 

PROVIDER: S-EPMC7389682 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature